RT @BrainTumorInst: What do we know about IDH1/2 mutations so far, and how do we use it? #TBT to a @CraigHorbinski classic: https://t.co/…
Excellent #neuropath paper on #IDH1 gliomas (Astros, Oligos, OligoAstros & Glioblastomas). The epigenetic section on ATRX and TET2 raises interesting questions. Clearly, there is still a great deal to be done on IDH1/2 in gliomas. Thank you @CraigHorbi
RT @BrainTumorInst: What do we know about IDH1/2 mutations so far, and how do we use it? #TBT to a @CraigHorbinski classic: https://t.co/…
What do we know about IDH1/2 mutations so far, and how do we use it? #TBT to a @CraigHorbinski classic: https://t.co/yIcFL8A7HJ
#FBF 5 years ago. Check out this @CraigHorbinski article explaining the role of IDH #mutations in #evaluation of #gliomas. https://t.co/VJ0mpyac9F
I'm reading What do we know about IDH1/2 mutations so far, and how do we use it? http://t.co/OCJ6PVIX8I